VANGUARD 7
VANGUARD 7
Not authorised
- Canine adenovirus 2, strain Manhattan, Live
- Canine parainfluenza virus, strain NL-CPI-5, Live
- Canine distemper virus, strain N-CDV, Live
- Canine parvovirus, strain NL-35-D, Live
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
Product identification
Medicine name:
VANGUARD 7
Active substance:
- Canine adenovirus 2, strain Manhattan, Live
- Canine parainfluenza virus, strain NL-CPI-5, Live
- Canine distemper virus, strain N-CDV, Live
- Canine parvovirus, strain NL-35-D, Live
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine adenovirus 2, strain Manhattan, Live1584.89/tissue culture infective dose 501.00unit(s)
-
Canine parainfluenza virus, strain NL-CPI-5, Live5011870.00/tissue culture infective dose 501.00unit(s)
-
Canine distemper virus, strain N-CDV, Live1000.00/tissue culture infective dose 501.00unit(s)
-
Canine parvovirus, strain NL-35-D, Live10000000.00/tissue culture infective dose 501.00unit(s)
-
Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated463.00/relative unit(s)1.00unit(s)
-
Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated420.00/relative unit(s)1.00unit(s)
Pharmaceutical form:
-
Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AI02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
-
Surrendered
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/6862556 2/1995
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 5/12/2022
How useful was this page?:
